ALTIMMUNE, INC. Comprehensive Income
ALTIMMUNE, INC. (ALT) reported Comprehensive Income of -$10.92 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2019-11-13
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$10.92M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$3.39M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$2.10M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2018-12-31 was -$24.51M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$39.63M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$43.43M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$17.89M.
- ALTIMMUNE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$3.21M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$10.92M 10-Q · filed 2019-11-13 | -$14.31M derived: sum of 2 quarters · filed 2019-11-13 | -$16.40M 10-Q · filed 2019-11-13 | -$40.91M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2019-06-30 | -$3.39M 10-Q · filed 2019-08-13 | -$5.48M 10-Q · filed 2019-08-13 | -$29.99M derived: sum of 3 quarters · filed 2019-08-13 | -$32.34M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2019-03-31 | -$2.10M 10-Q · filed 2019-05-14 | -$26.60M derived: sum of 2 quarters · filed 2019-05-14 | -$28.96M derived: sum of 3 quarters · filed 2019-11-13 | -$39.17M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-12-31 | -$24.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$26.86M derived: sum of 2 quarters · filed 2019-11-13 | -$37.08M derived: sum of 3 quarters · filed 2019-11-13 | -$39.63M 10-K · filed 2019-04-01 | ||||
| 2018-09-30 | -$2.35M 10-Q · filed 2019-11-13 | -$12.57M derived: sum of 2 quarters · filed 2019-11-13 | -$15.13M 10-Q · filed 2019-11-13 | -$18.10M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$10.22M 10-Q · filed 2019-08-13 | -$12.78M 10-Q · filed 2019-08-13 | -$15.74M derived: sum of 3 quarters · filed 2019-08-13 | -$46.68M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$2.56M 10-Q · filed 2019-05-14 | -$5.53M derived: sum of 2 quarters · filed 2019-05-14 | -$36.46M derived: sum of 3 quarters · filed 2019-05-14 | -$38.31M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$33.90M derived: sum of 2 quarters · filed 2019-04-01 | -$35.76M derived: sum of 3 quarters · filed 2019-04-01 | -$43.43M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | -$30.93M 10-Q · filed 2018-11-13 | -$32.79M derived: sum of 2 quarters · filed 2018-11-13 | -$40.46M 10-Q · filed 2018-11-13 | -$41.53M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$1.85M 10-Q · filed 2018-08-14 | -$5.85M 10-Q · filed 2018-08-14 | -$10.60M derived: sum of 3 quarters · filed 2018-08-14 | -$16.71M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$4.00M 10-Q · filed 2018-05-15 | -$2.20M 10-Q · filed 2017-05-03 | -$8.75M derived: sum of 2 quarters · filed 2018-05-15 | -$14.86M derived: sum of 3 quarters · filed 2018-05-15 | -$19.09M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$10.86M derived: sum of 2 quarters · filed 2018-04-02 | -$15.09M derived: sum of 3 quarters · filed 2018-04-02 | -$17.89M 10-K · filed 2018-04-02 | $193.85M 10-K · filed 2017-03-14 | |||
| 2016-09-30 | -$6.11M 10-Q · filed 2017-11-09 | $109.25M 10-Q · filed 2016-11-04 | -$10.34M derived: sum of 2 quarters · filed 2017-11-09 | -$13.15M 10-Q · filed 2017-11-09 | $116.06M 10-Q · filed 2016-11-04 | -$12.81M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$4.23M 10-Q · filed 2017-08-14 | $8.04M 10-Q · filed 2016-08-04 | -$7.03M 10-Q · filed 2017-08-14 | $6.82M 10-Q · filed 2016-08-04 | -$6.70M derived: sum of 3 quarters · filed 2017-08-14 | -$8.02M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | -$1.23M 10-Q · filed 2017-05-03 | -$2.47M derived: sum of 2 quarters · filed 2017-05-03 | -$3.79M derived: sum of 3 quarters · filed 2017-05-03 | -$5.90M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$2.56M derived: sum of 2 quarters · filed 2017-03-14 | -$4.68M derived: sum of 3 quarters · filed 2017-03-14 | -$3.21M 10-K · filed 2017-03-14 | ||||
| 2015-09-30 | -$1.32M 10-Q · filed 2016-11-04 | -$3.44M derived: sum of 2 quarters · filed 2016-11-04 | -$1.97M 10-Q · filed 2016-11-04 | -$4.61M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | -$2.11M 10-Q · filed 2016-08-04 | -$648.01K 10-Q · filed 2016-08-04 | -$3.28M derived: sum of 3 quarters · filed 2017-03-14 | -$7.92M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | $1.47M 10-Q · filed 2016-05-09 | -$1.17M derived: sum of 2 quarters · filed 2017-03-14 | -$5.80M derived: sum of 3 quarters · filed 2017-03-14 | -$6.24M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$7.27M derived: sum of 2 quarters · filed 2017-03-14 | -$7.71M derived: sum of 3 quarters · filed 2017-03-14 | -$9.97M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | -$4.63M 10-Q · filed 2015-11-06 | -$5.07M derived: sum of 2 quarters · filed 2015-11-06 | -$7.33M 10-Q · filed 2015-11-06 | |||||
| 2014-06-30 | -$439.76K 10-Q · filed 2015-08-05 | -$2.70M 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | -$2.26M 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | -$11.72M 10-K · filed 2016-03-11 | |||||||
| 2012-09-30 | -$1.43M 10-Q · filed 2012-11-06 | -$2.21M derived: sum of 2 quarters · filed 2012-11-06 | -$4.88M 10-Q · filed 2012-11-06 | -$4.28M derived: sum of 4 quarters · filed 2012-11-06 | ||||
| 2012-06-30 | -$776.45K 10-Q · filed 2012-08-07 | -$3.44M 10-Q · filed 2012-08-07 | -$2.84M derived: sum of 3 quarters · filed 2012-08-07 | -$2.96M derived: sum of 4 quarters · filed 2012-11-06 | ||||
| 2012-03-31 | -$2.67M 10-Q · filed 2012-05-10 | -$2.07M derived: sum of 2 quarters · filed 2012-05-10 | -$2.18M derived: sum of 3 quarters · filed 2012-11-06 | -$4.61M derived: sum of 4 quarters · filed 2012-11-06 | ||||
| 2011-12-31 | $598.10K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $485.01K derived: sum of 2 quarters · filed 2012-11-06 | -$1.94M derived: sum of 3 quarters · filed 2012-11-06 | -$4.04M 10-K · filed 2012-03-08 | ||||
| 2011-09-30 | -$113.08K 10-Q · filed 2012-11-06 | -$2.54M derived: sum of 2 quarters · filed 2012-11-06 | -$4.64M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | -$2.42M 10-Q · filed 2012-08-07 | -$4.52M 10-Q · filed 2012-08-07 | ||||||
| 2011-03-31 | -$2.10M 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | -$34.79M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |